| Product Code: ETC9959094 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Allergy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Allergy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Allergy Market - Industry Life Cycle |
3.4 United States (US) Allergy Market - Porter's Five Forces |
3.5 United States (US) Allergy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Allergy Market Revenues & Volume Share, By Allergan Type, 2021 & 2031F |
3.7 United States (US) Allergy Market Revenues & Volume Share, By Disease Areas, 2021 & 2031F |
3.8 United States (US) Allergy Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 United States (US) Allergy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 United States (US) Allergy Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 United States (US) Allergy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Allergy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of allergies in the US population |
4.2.2 Rising awareness and diagnosis of allergies |
4.2.3 Technological advancements in allergy testing and treatment |
4.2.4 Growing demand for over-the-counter allergy medications |
4.2.5 Changes in lifestyle and environmental factors contributing to allergies |
4.3 Market Restraints |
4.3.1 High cost of allergy testing and treatment |
4.3.2 Stringent regulatory requirements for allergy medication approval |
4.3.3 Limited access to specialized allergy care in certain regions |
4.3.4 Side effects associated with some allergy medications |
4.3.5 Competition from alternative therapies and remedies |
5 United States (US) Allergy Market Trends |
6 United States (US) Allergy Market, By Types |
6.1 United States (US) Allergy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Allergy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Allergy Market Revenues & Volume, By Antihistamines, 2021- 2031F |
6.1.4 United States (US) Allergy Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.5 United States (US) Allergy Market Revenues & Volume, By Decongestants, 2021- 2031F |
6.1.6 United States (US) Allergy Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.1.7 United States (US) Allergy Market Revenues & Volume, By Mast Cell Stabilizers, 2021- 2031F |
6.1.8 United States (US) Allergy Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.2 United States (US) Allergy Market, By Allergan Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Allergy Market Revenues & Volume, By Airborne Allergens, 2021- 2031F |
6.2.3 United States (US) Allergy Market Revenues & Volume, By Food Allergens, 2021- 2031F |
6.2.4 United States (US) Allergy Market Revenues & Volume, By Insect Stings/ Bites, 2021- 2031F |
6.2.5 United States (US) Allergy Market Revenues & Volume, By Drug Allergens, 2021- 2031F |
6.2.6 United States (US) Allergy Market Revenues & Volume, By Metal/ Chemical Allergens, 2021- 2031F |
6.2.7 United States (US) Allergy Market Revenues & Volume, By Animal Saliva, 2021- 2031F |
6.3 United States (US) Allergy Market, By Disease Areas |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Allergy Market Revenues & Volume, By Allergic Rhinitis, 2021- 2031F |
6.3.3 United States (US) Allergy Market Revenues & Volume, By Atopic Dermatitis, 2021- 2031F |
6.3.4 United States (US) Allergy Market Revenues & Volume, By Conjunctivitis, 2021- 2031F |
6.3.5 United States (US) Allergy Market Revenues & Volume, By Urticaria, 2021- 2031F |
6.3.6 United States (US) Allergy Market Revenues & Volume, By Asthma, 2021- 2031F |
6.3.7 United States (US) Allergy Market Revenues & Volume, By Anaphylaxis, 2021- 2031F |
6.3.8 United States (US) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.3.9 United States (US) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Allergy Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Allergy Market Revenues & Volume, By Liquid, 2021- 2031F |
6.4.3 United States (US) Allergy Market Revenues & Volume, By Solid, 2021- 2031F |
6.4.4 United States (US) Allergy Market Revenues & Volume, By Semi-Solid, 2021- 2031F |
6.5 United States (US) Allergy Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Allergy Market Revenues & Volume, By Nasal, 2021- 2031F |
6.5.3 United States (US) Allergy Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.4 United States (US) Allergy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5.5 United States (US) Allergy Market Revenues & Volume, By Topical, 2021- 2031F |
6.5.6 United States (US) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Allergy Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Allergy Market Revenues & Volume, By Prescription, 2021- 2031F |
6.6.3 United States (US) Allergy Market Revenues & Volume, By Over the Counter, 2021- 2031F |
6.7 United States (US) Allergy Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 United States (US) Allergy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 United States (US) Allergy Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 United States (US) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 United States (US) Allergy Market Revenues & Volume, By Others, 2021- 2031F |
6.8 United States (US) Allergy Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 United States (US) Allergy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.8.3 United States (US) Allergy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.8.4 United States (US) Allergy Market Revenues & Volume, By Competitive Lands, 2021- 2031F |
6.8.5 United States (US) Allergy Market Revenues & Volume, By Competitive Lands, 2021- 2031F |
7 United States (US) Allergy Market Import-Export Trade Statistics |
7.1 United States (US) Allergy Market Export to Major Countries |
7.2 United States (US) Allergy Market Imports from Major Countries |
8 United States (US) Allergy Market Key Performance Indicators |
8.1 Number of allergy-related doctor visits in the US |
8.2 Adoption rate of new allergy testing technologies |
8.3 Percentage of population using allergy medications as a preventive measure |
8.4 Research and development investment in allergy treatment options |
8.5 Patient satisfaction and outcomes with allergy management strategies |
9 United States (US) Allergy Market - Opportunity Assessment |
9.1 United States (US) Allergy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Allergy Market Opportunity Assessment, By Allergan Type, 2021 & 2031F |
9.3 United States (US) Allergy Market Opportunity Assessment, By Disease Areas, 2021 & 2031F |
9.4 United States (US) Allergy Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 United States (US) Allergy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 United States (US) Allergy Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 United States (US) Allergy Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 United States (US) Allergy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Allergy Market - Competitive Landscape |
10.1 United States (US) Allergy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Allergy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here